Pre-biopsy prostate-specific antigen velocity does not predict gleason score, tumor location or cancer volume following transperineal-template guided prostate mapping biopsy: Implications for prostate brachytherapy treatment planning

被引：1
|
作者：
Bittner, N. [1 ]
Merrick, G. S. [2 ]
Wallner, K. E. [3 ]
Butler, W. M. [2 ]
Anderson, R. L. [2 ]
Allen, Z. A. [2 ]
Adamovich, E. [4 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Schiffler Canc Ctr, Wheeling, WV USA
[3] Puget Sound Healthcare Corp, Seattle, WA USA
[4] Wheeling Hosp, Dept Pathol, Wheeling, WV USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 48 条
  • [41] The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting
    Hansen, Nienke L.
    Barrett, Tristan
    Koo, Brendan
    Doble, Andrew
    Gnanapragasam, Vincent
    Warren, Anne
    Kastner, Christof
    Bratt, Ola
    BJU INTERNATIONAL, 2017, 119 (05) : 724 - 730
  • [42] Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy
    Jue, Joshua S.
    Barboza, Marcelo Panizzutti
    Prakash, Nachiketh S.
    Venkatramani, Vivek
    Sinha, Varsha R.
    Pavan, Nicola
    Nahar, Bruno
    Kanabur, Pratik
    Ahdoot, Michael
    Dong, Yan
    Satyanarayana, Ramgopal
    Parekh, Dipen J.
    Punnen, Sanoj
    UROLOGY, 2017, 105 : 123 - 128
  • [43] Prostate-specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study)
    Inoue, Takaaki
    Yoshimura, Koji
    Terada, Naoki
    Tsukino, Hiromasa
    Murota, Takashi
    Kinoshita, Hidefumi
    Kamoto, Toshiyuki
    Ogawa, Osamu
    Matsuda, Tadashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (08) : 849 - 854
  • [44] Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
    Yamamoto, S
    Ito, T
    Aizawa, T
    Noda, K
    Umezu, K
    Ohtsuru, N
    Hata, K
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (06) : 386 - 391
  • [45] Commentary RE: Contemporary Update of Prostate Cancer Staging Nomograms (Partin Tables) for the New Millennium and Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005
    Partin, Alan W.
    UROLOGY, 2020, 145 : 321 - 321
  • [46] Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very Low-risk and Low-risk Prostate Cancer Implications for Active Surveillance
    Merrick, Gregory S.
    Delatore, Alexandra
    Butler, Wayne M.
    Bennett, Abbey
    Fiano, Ryan
    Anderson, Richard
    Adamovich, Edward
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 53 - 59
  • [47] Rise in PSA following intramuscular testosterone injection correlates highly with tumor volume and gleason sum in men with PSA levels between 2.4 to 4 diagnosed with prostate cancer following transrectal ultrasound-guided prostate biopsy
    Shulman, MJ
    Margulis, V
    Benaim, E
    JOURNAL OF UROLOGY, 2005, 173 (04): : 396 - 396
  • [48] Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score of ≤6, and their influence on PSA progression-free survival after radical prostatectomy
    Weckermann, D
    Goppelt, M
    Dorn, R
    Wawroschek, F
    Harzmann, R
    BJU INTERNATIONAL, 2006, 97 (06) : 1173 - 1178
12345